Headline
[ by | Apr 18, 2012 10:23 am | Comments Off ]
Single-Pill Treatment Is Associated With Better Treatment Adherence In People With HIV

Results from a recent study suggest that people with HIV whose antiretroviral regimen is taken as a single pill per day have better treatment adherence and a lower risk of hospitalization compared with people whose regimens consist of three or more pills per day.

“This study found that patients who receive [antiretroviral therapy] as a single pill per day are significantly more likely to be highly adherent to therapy. Furthermore, receiving a single pill per day was associated with a lower risk of hospitalization when compared with receiving multiple pills per day,” wrote the study authors.

“Although this study could not assess causality, it did show that receiving [antiretroviral therapy] as a single pill per day was associated with potential clinical and economic benefits,” they added.

According to the study investigators, high, sustained treatment adherence is necessary throughout a patient’s lifetime for optimal treatment outcomes. Studies in patients …

Read the full story »
[ by | Apr 11, 2012 10:13 am | Comments Off ]
Metabolic Syndrome Differs Between Treated And Untreated People With HIV

Results from a recent Italian study indicate that people with HIV, both on and off antiretroviral therapy, have similar low rates of metabolic syndrome, a condition which includes pre-diabetes, obesity, and other features.

However, the results also indicated that the symptoms of metabolic syndrome were different in previously untreated patients versus those in patients receiving highly active antiretroviral therapy.

Based on the results, the study investigators concluded that people with HIV who are on antiretroviral therapy develop metabolic syndrome differently than people who have not been treated.

According to the …

Read the full story »
[ by | Apr 4, 2012 5:58 am | Comments Off ]
Stimulation Of HIV-Specific Immune Cells Is Necessary To Eliminate Latent HIV

Results from a recent study suggest that stimulation of immune cells that specifically target HIV is necessary to eradicate latent HIV. The results also suggest that simply activating latent HIV is not sufficient to eliminate the virus from the body.

Based on the results, the researchers suggested that boosting immune responses through vaccination, followed by reactivation of latent HIV, may be an effective strategy for eradicating HIV.

Latent HIV is HIV that is not actively replicating. Since antiretroviral drugs usually work by blocking replication, they do not work on latent …

Read the full story »